Medcolcanna Organics Inc. Share Price Deutsche Boerse AG

Equities

MO2

CA58406X1050

Pharmaceuticals

Delayed Deutsche Boerse AG 07:11:41 11/07/2022 BST 5-day change 1st Jan Change
0.0005 EUR -.--% Intraday chart for Medcolcanna Organics Inc. -.--% -.--%

Financials

Sales 2019 1.58K 1.16K 1.07K 91.06K Sales 2020 95.77K 70.13K 64.73K 5.51M Capitalization 8.09M 5.92M 5.46M 465M
Net income 2019 -7M -5.13M -4.73M -403M Net income 2020 -7M -5.13M -4.73M -403M EV / Sales 2019 4,531 x
Net cash position 2019 2.32M 1.7M 1.57M 133M Net Debt 2020 2.98M 2.18M 2.01M 171M EV / Sales 2020 116 x
P/E ratio 2019
-1.04 x
P/E ratio 2020
-1 x
Employees 90
Yield 2019 *
-
Yield 2020
-
Free-Float 41.37%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0.0005
0.07
5 years
0.00
Extreme 0.0005
0.09
10 years
0.00
Extreme 0.0005
0.09
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 16/05/19
Director of Finance/CFO 46 16/05/19
Chief Tech/Sci/R&D Officer - 31/03/19
Members of the board TitleAgeSince
Chairman 84 16/05/19
Director of Finance/CFO 46 16/05/19
Chief Executive Officer 44 16/05/19
More insiders
Medcolcanna Organics Inc. is a Canadian integrated medical cannabis company, whose fully licensed operations are based in Colombia. The Company is engaged in the cultivation and conversion of cannabis into raw materials, commodities, and finished cannabis products for the global market, such as nutraceuticals, cosmetics, and medicinal products. It is also engaged in providing extraction services and involved in the cannabis distribution and vaping industry. Its products and services portfolio include commodities, white label services and other services. Its other services include in vitro plants, cuttings, fresh and dry flower, biomass, third party crop operation, and technical assistance. The Company, through its subsidiary, Medcolcanna S.A.S, is engaged in sowing and cultivation of psychoactive and non-psychoactive cannabis plants, and manufacturing of cannabis derivatives in Colombia. Its other subsidiaries include Extralia Labs SAS and MCCN SA.
More about the company